Jolly Good, a Tokyo-based medical VR company, has established a North American subsidiary to expand its presence in the region. They plan to focus on developing medical VR content for "Apple Vision Pro."
Their initial project involves creating a cognitive behavioural therapy program for chronic pain, in collaboration with U.S. expert John D. Otis. The goal is to provide a non-drug alternative for chronic pain management in response to the opioid abuse problem in the United States.
Jolly Good aims to verify the effectiveness of this program and expand its offerings to cover other psychiatric disorders, with a focus on the global market. This expansion represents Jolly Good's commitment to advancing healthcare through immersive technology.
Click here to read the original news story.